Topics

High-grade gliomas | Treatment | Chemotherapy | Taxanes

Home > Publications > Topics > High-grade gliomas > Treatment > Chemotherapy > Taxanes

Dmello C, Brenner A, Piccioni D, Wen PY, Drappatz J, Mrugala M, Lewis LD, Schiff D, Fadul CE, Chamberlain M, Kesari S, Ahluwalia M, Ghosh D, Sonabend AM, Kumthekar P.
Phase II trial of blood-brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade glioma.
Neurooncol Adv. 2024 Dec 14;6(1):vdae186. doi: 10.1093/noajnl/vdae186. PMID: 39713041. Interventional study. ˍ

Jia Z, Jiang T, Zhang Y, Chen Q, Di Z, Yuan Q, Qian K, Gan L, Ma C, Lin X.
Clinical Efficacy and Safety Assessment of Specific-Mode Electroacupuncture Stimulation Combined With Paclitaxel for Recurrent Malignant Gliomas: Study Protocol for a Single-Arm Trial.
JMIR Res Protoc. 2026 Jan 29;15:e84593. doi: 10.2196/84593. PMID: 41610368. Interventional study protocol. ˍ